These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10672313)

  • 1. Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain.
    Yoshiyama Y; Asahina M; Hattori T
    Acta Neuropathol; 2000 Feb; 99(2):91-5. PubMed ID: 10672313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain.
    Asahina M; Yoshiyama Y; Hattori T
    Clin Neuropathol; 2001; 20(2):60-3. PubMed ID: 11327298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P38 MAP kinase is activated at early stages in Alzheimer's disease brain.
    Sun A; Liu M; Nguyen XV; Bing G
    Exp Neurol; 2003 Oct; 183(2):394-405. PubMed ID: 14552880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology.
    Su JH; Zhao M; Anderson AJ; Srinivasan A; Cotman CW
    Brain Res; 2001 Apr; 898(2):350-7. PubMed ID: 11306022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease.
    Horstmann S; Budig L; Gardner H; Koziol J; Deuschle M; Schilling C; Wagner S
    Int Psychogeriatr; 2010 Sep; 22(6):966-72. PubMed ID: 20561382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of a repulsive axonal guidance molecule RGMa in amyloid plaques: a possible hallmark of regenerative failure in Alzheimer's disease brains.
    Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K
    Neuropathol Appl Neurobiol; 2013 Feb; 39(2):109-20. PubMed ID: 22582881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease.
    Baig S; Kehoe PG; Love S
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):205-15. PubMed ID: 17971072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes.
    Robinson SR
    Neurochem Int; 2000 Apr; 36(4-5):471-82. PubMed ID: 10733015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.
    Clark EA; Leach KL; Trojanowski JQ; Lee VM
    Lab Invest; 1991 Jan; 64(1):35-44. PubMed ID: 1990207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
    Hyman BT; Tanzi RE; Marzloff K; Barbour R; Schenk D
    J Neuropathol Exp Neurol; 1992 Jan; 51(1):76-83. PubMed ID: 1740675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease.
    Ogawa K; Yamada T; Tsujioka Y; Taguchi J; Takahashi M; Tsuboi Y; Fujino Y; Nakajima M; Yamamoto T; Akatsu H; Mitsui S; Yamaguchi N
    Psychiatry Clin Neurosci; 2000 Aug; 54(4):419-26. PubMed ID: 10997858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
    Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
    Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulation.
    Laitinen KS; van Groen T; Tanila H; Venäläinen J; Männistö PT; Alafuzoff I
    Neuroreport; 2001 Oct; 12(15):3309-12. PubMed ID: 11711876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease.
    Leake A; Morris CM; Whateley J
    Neurosci Lett; 2000 Sep; 291(3):201-3. PubMed ID: 10984641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the membrane-type 3 matrix metalloproteinase (MT3-MMP) in human brain tissues.
    Yoshiyama Y; Sato H; Seiki M; Shinagawa A; Takahashi M; Yamada T
    Acta Neuropathol; 1998 Oct; 96(4):347-50. PubMed ID: 9796998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin.
    Cataldo AM; Thayer CY; Bird ED; Wheelock TR; Nixon RA
    Brain Res; 1990 Apr; 513(2):181-92. PubMed ID: 2350688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).
    Backstrom JR; Lim GP; Cullen MJ; Tökés ZA
    J Neurosci; 1996 Dec; 16(24):7910-9. PubMed ID: 8987819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytes and the plaques of Alzheimer's disease.
    Mandybur TI; Chuirazzi CC
    Neurology; 1990 Apr; 40(4):635-9. PubMed ID: 1690867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of clathrin light chains in the pathology of Alzheimer's disease.
    Nakamura Y; Takeda M; Yoshimi K; Hattori H; Hariguchi S; Kitajima S; Hashimoto S; Nishimura T
    Acta Neuropathol; 1994; 87(1):23-31. PubMed ID: 8140893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleomycin hydrolase immunoreactivity in senile plaque in the brains of patients with Alzheimer's disease.
    Namba Y; Ouchi Y; Takeda A; Ueki A; Ikeda K
    Brain Res; 1999 May; 830(1):200-2. PubMed ID: 10350576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.